Navigation Links
AMDL, Inc. Announces 2009 Financial Guidance and First Quarter Business Objectives
Date:1/26/2009

sult in an additional US$25 million in gross revenues and plans to provide formal revenue guidance for these products in the second quarter of 2009.

To achieve its fiscal year 2009 revenue projections, AMDL will execute three key business strategies that include:

  • Launching at least eight new Human Placenta Extract (HPE) product formulations, expanding the sales of our HPE anti-aging products to at least 36 additional Chinese markets serving over 1 million people and exporting select HPE product formulations to strategic international markets.

  • Commercializing the AMDL ELISA DR-70 (FDP) cancer monitoring test in the U.S. for monitoring of colorectal cancer and developing and marketing the product as a complementary test to other existing molecular diagnostic tests. Specifically, the Company expects to the sell the AMDL DR-70 ELISA (FDP) cancer test as a lung cancer screening test in Canada, as a general cancer screening test in Korea, Taiwan, Europe, and other non-harmonized countries in the Asian-Pacific market, and as a general cancer screen and/or a cancer specific test in Latin America and the Middle East.

  • Continuing aggressive sales of the Company's top-selling pharmaceutical products in China with a focus on expanding to at least 36 additional Chinese markets serving over 1 million people.

In fiscal year 2008 pharmaceutical product sales through AMDL's China-based wholly-owned subsidiary Jade Pharmaceuticals Inc. (JPI), which has sole ownership of two China-based pharmaceutical companies (Jiangxi Shangrao Kangda Pharmacy Co., Ltd. (JJB) and Yangbian Yiqiao Biochemistry Pharmacy Co., Ltd. (YYB), accounted for approximately 97% of the Company's total sales; and sales of the AMDL ELISA DR-70 (FDP) cancer test accounted for the remaining 3% of
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
2. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
3. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
6. AMDL, Inc. Announces Strategic Realignment
7. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
8. AMDL, Inc.s President & CEO Mr. Gary Dreher Retires
9. AMDL, Inc. Names Douglas MacLellan as Executive Chairman & CEO
10. AMDL, Inc. Promotes CFO Akio Ariura to Chief Operating Officer and Expands Management Team
11. AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)...  HireLifeScience.com, the premier career networking website for ... th annual career fair at The NJ ... Edison, NJ on September ... Actavis and AstraZeneca.  Additional Pharmaceutical, Biotechnology and Medical ... & Johnson, MedImmune, DSM Nutritional Products, LifeCell, Duke ...
(Date:6/3/2015)... 2015 The National Center for ... record by scaling CD-adapco’s flagship simulation tool STAR-CCM+® ... , STAR-CCM+ is a comprehensive multidisciplinary engineering ... innovation and lower product development costs. CD-adapco joined ... manufacturer Cray to push the code to new ...
(Date:6/3/2015)... 03, 2015 From smart street lighting ... part in enabling success in dealing with important Societal ... leaders helped bring focus to the role and further ... Photonics21 annual meeting last week in Brussels. ... held 28 and 29 May at the Hotel Le ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6wjpd6/bioburden_testing ) has announced the ... , Test, Application & End User - Forecast to ... bioburden testing market is expected to reach $565.6 Million ... a CAGR of 9.8% from 2014 to 2019 ... market is segmented into consumables and instruments. The consumables ...
Breaking Biology Technology:AstraZeneca Added as Sponsor for Industry Leading Life Science Hiring Event 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 3Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3Bioburden Testing Market 2015 - Global Forecasts to 2019 2
... a private,biotechnology company and leading developer of clean ... Singapore,Pte. Ltd. (CLS). CLS is the company,s first ... the company,s research and development operations in the,U.S. ... business in,both the innovator and generics markets. ...
... Inc. (Amex: PLX ), announced today the pricing ... common stock at a,public offering price of $5.00 per ... underwriters to purchase up to 1,500,000 additional shares of,common ... Bank is acting as sole book-running manager for this,offering. ...
... Inc. (Nasdaq: HGSI ) today announced that it ... for the quarter ended,September 30, 2007. These results are ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) The conference call will ... Thursday, November 1, 2007, at 11:00 am Eastern Time. ...
Cached Biology Technology:Codexis Opens Singapore Laboratory 2Protalix BioTherapeutics Announces Pricing of Public Offering of Common Stock 2Human Genome Sciences To Sponsor Conference Call To Discuss Third Quarter 2007 Financial Results 2
(Date:4/27/2015)... Fla. , Apr. 27, 2015 Profile ... access control and security systems is pleased to announce ... company as a consultant and member of its scientific ... is widely known as a thought leader in technology-enhanced ... Learning Technology Group, and has published studies and books ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... at the IRCM in Montral found a possible alternative ... the IRCM,s President and Scientific Director, the team discovered ... could be targeted to develop a new approach that ... as chemotherapy and radiation therapy. The study,s results are ...
... created a new method to generate bone cells which could ... fractures or those who need hip replacement surgery due to ... Emmajayne Kingham at the University of Southampton in collaboration with ... Small , cultured human embryonic stem cells on to the ...
... for Valentine,s Day, the American Chemical Society (ACS), the world,s ... video today featuring five chemistry facts that highlight why chocolate, ... by the ACS Office of Public Affairs, is available at ... of chocolate contains hundreds of compounds, many with beneficial properties. ...
Cached Biology News:Researchers discover 'Achilles' heel' for lymphoid leukemia 2Stem cell breakthrough could lead to new bone repair therapies on nanoscale surfaces 2